AstraZeneca makes third investment of Rs 176 crore in India

AstraZeneca, a worldwide, science-led, patient-focused pharmaceutical firm devoted to accelerating the supply of life-changing medicines, has introduced a strategic investment of Rs 176 crore, the third such investment in the previous two years in India.

This new investment is targeted on increasing the capabilities and infrastructure at its Global Innovation & Technology Centre (GITC) in Chennai to strengthen its place as a frontrunner in healthcare innovation each globally and in India.

AstraZeneca’s expanded presence in the nation will gas the event of superior expertise capabilities, foster high-value job creation, and deepen collaborations with native expertise swimming pools and companions in Tamil Nadu and India. Additionally, this step will assist speed up the supply of next-generation medicines, assist digital and data-driven options, and assist form future-ready healthcare ecosystems. 

“We’re proud to bolster our dedication to the nation’s vibrant scientific and technological neighborhood. This new investment displays our ongoing mission to enhance affected person lives by embedding cutting-edge applied sciences into each facet of our work. Chennai continues to evolve as a significant innovation hub, and our continued progress right here demonstrates the state’s boundless potential”, mentioned Siva Padmanabhan, Managing Director, AstraZeneca India Private Limited.

The investment helps the expansion of AstraZeneca’s world-class expertise and innovation groups, together with specialists in synthetic intelligence, knowledge analytics, machine studying, knowledge science, and provide chain analytics to form and rework healthcare outcomes. The GITC will profit immensely from upgraded and extra capability, designed to allow collaborative analysis and transformative options that handle complicated healthcare challenges.

MK Stalin-Chief Minister Tamil Nadu mentioned, “AstraZeneca has played a significant role in shaping an ecosystem that integrates technology with healthcare ultimately changing the way people are accessing healthcare in the country. This additional investment in Chennai is a testament to state’s reputation as a centre of excellence for global innovation. This partnership will generate skilled opportunities, encourage knowledge exchange, and reinforce Tamil Nadu’s status as a premier destination for forward-looking industries.”